NEW YORK, NY, May 02, 2018, — ASGARD Partners & Co. (“ASGARD”) is pleased to announce that is has advised Avadim Technologies Inc. (“Avadim”), the Bionome TherapiesTM life sciences company, on its $17 million equity and debt financing round.  Both existing and new investors participated in the deal.

Steve Woody, Chairman and CEO of Avadim, stated, “The financing represents the accomplishment of a major milestone in our overall capitalization plan.  The company intends to utilize the net proceeds from this financing round primarily to invest in sales and marketing to drive execution and continue to accelerate its impressive growth trajectory.  We would like to thank ASGARD for their relentless support in helping us manage the process to close this transaction.  ASGARD’s strong understanding of the life sciences sector and its ability to help navigate structuring and financial challenges resulted in a great outcome for all parties.  A special thanks to our shareholders, because without their generous support, none of this would be possible.”

“We are honored to represent Avadim in this process and help them reach this important milestone.  This funding enables Avadim to broaden its reach as it strives to address significant unmet health needs in hospitals and for consumers with its revolutionary technology platform.  We look forward to a continued partnership with Steve and his stellar management team,” said Nicholas Desjardins, Partner & Head of Advisory Services at ASGARD.

ASGARD Partners & Co. is a next generation financial firm combining private equity investments and capital markets advisory into one platform to better and more effectively serve portfolio companies, clients and investors.  ASGARD believes business is a powerful platform that can change the world for the better and is committed to serving entrepreneurs, companies, and investors that share this belief.  The partners at ASGARD have collectively arranged and advised on more than $65 billion in transactions and have proven expertise across a wide spectrum of advisory services.  ASGARD brings multi-functional capabilities to its clients and enables them to navigate their capital and growth decisions effectively.  For more information, visit

About Avadim Technologies Inc.:

Based in Asheville, NC, Avadim is a rapidly growing life sciences company built around the concept of serving.  With a mission to change lives and transform communities, Avadim identifies unmet needs and addresses them in a way nobody else has.  The company offers a portfolio of advanced, safe solutions and has a strong pipeline across a broad range of health and wellness areas.

ASGARD Media Contact:
Robert Beall

All private placements of securities are offered through, Brokerage Services LLC Member: FINRA/SIPCASGARD Partners & Co., LLC and are independent and not affiliated. None of the aforementioned firms provide legal, tax or investment advice and are not authorized to do so. Information about any securities offering should not be considered complete and is qualified by the full offering documents corresponding to a particular project financing. This email does not constitute an offer of, or the solicitation of an offer to buy or subscribe for, any securities to any person in any jurisdiction to whom or in which such offer or solicitation is unlawful. All communications by ASGARD Partners & Co., LLC and or any of its directors, officers, employees, representatives, affiliates or agents, are modified by the Terms of Use and Privacy Policy posted on the website at ASGARD Partners & Co., LLC and